July 24, 2024

Iceberg Biotechnology

Water, Biotechnology Grade

42300008-1 1 gal
EUR 33.07

Icebergbiotech Laboratories manufactures the iceberg biotechnology reagents distributed by Genprice. The Iceberg Biotechnology reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Icebergbiotech. Other Iceberg products are available in stock. Specificity: Iceberg Category: Biotechnology

True Blue

5mg Ask for price
Description: True Blue

True Blue

EUR 635

True Blue

EUR 2705

3M Sodium Acetate, pH5.2, Biotechnology Grade, 500ml

each Ask for price

JBS True Blue

EUR 13.7

True Blue Chloride

EUR 11200
Description: 71431-30-6

JBS True Blue

300 µl
EUR 16
Description: JBS True Blue

Biology information

ICEBERG (CARD18) (NM_021571) Human Over-expression Lysate

LS059082 100ug
EUR 628
Description: Transient overexpression lysate of caspase recruitment domain family, member 18 (CARD18)

SevenCompact(TM) pH meter S210 biotechn - EACH

MT30130864-1EA EACH
EUR 1511.4

Tris - Biotech Grade

TB0196 500g
EUR 86.1

Multi shelf rack For RS Biotech Galaxy 48R - EACH

EUR 502.2

DL-Dithiothreitol/DTT - biotech grade

ADC-P-082 unit Ask for price

Perforated Shelf For RS Biotech Galaxy 14 - EACH

EUR 187.65

Magnesium sulfate, heptahydrate, biotech

MRB0329 500g
EUR 76.7

Additional perforated shelf For RS Biotech Galaxy 48R - EACH

EUR 143.1

Anti-BST2 / CD317 Reference Antibody (SBI Biotech anti-BST2)

E24CHB092 100 μg
EUR 225
Description: Available in various conjugation types.


YF-PA20343 50 ug
EUR 435.6
Description: Mouse polyclonal to ICEBERG

Biotin-Ova (323-339)

SB075 1
EUR 126.23
Description: Biotin-Ova (323-339) is the N-ter biotinylated version of Ova (323-339). Biotin-Ova (323-339) can be used in the analysis of antigen-specific T cells. Ovalbumin protein: Ova (323-339) is an epitope of interest of the egg white albumen, which is widely used in allergy research. Ovalbumin is a glycoprotein that is sufficiently large and complex to be mildly immunogenic. Indeed, it has been demonstrated that Ovalbumin contains B-cell epitopes which are recognized by specific IgE antibodies and CD4 T cell epitopes restricted by the MHC I-Ad molecule in mice and by HLA-D molecule in human.Applications of Ova (323-339):Ova (323-339) allows to study bindings of class II MHC-peptide and T-cell activation in PBMCs by ELISPOT assays. In fact, this method quantifies peptide epitope specificity and IFN-γ releasing effector cells. It has been shown that Ova (323-339) was responsible for 25-35% of T-cell response of isolated BALB/c mouse. An investigation has demonstrated that Ova and Ova (323-339) induced similar lung inflammation and a Th2-like dominant immune response in mouse model. Sequence: Biotin-ISQAVHAAHAEINEAGR

Biotin-FluM1 (58-66)

SB074 1
EUR 182.33
Description: Biotin-FluM1 (58-66) is the N-ter biotinylated version of FluM1 (58-66). Biotin-FluM1 (58-66) can be used in the analysis of antigen-specific T cells.FluM1 (58-66):FluM1 (58-66) is a short part of the matrix protein of Influenza A virus which is the most abundant component of this enveloped virus localized under the viral lipid envelope. The GILGFVFTL epitope is highly conserved in Influenza A virus strains at a rate of 93% for 69 strains tested. Human Influenza epitopes may bind MHC molecules and then may be recognized by CD8+ cytotoxic T cells. Applications of FluM1 (58-66):FluM1 (58-66) is used to stimulate CTL responses in peripheral blood mononuclear cells (PBMCs). Then, ELISPOT assay is used to quantify peptide epitope specificity and IFN-γ releasing effector cells.FluM1 (58-66) has shown CTL responses qualified of immunodominant with restriction by HLA-A*02:01. It has also been detected CTL responses when FluM1 (58-66) is restricted by all HLA-C. Therefore, FluM1 (58-66) may help to understand the reaction of immune system against Influenza virus of each populations having different HLA type.FluM1 (58-66) has indeed prompted research to develop T-cell vaccine strategies capable of inducing specific CTL responses in patients upon immunization with Influenza M1 antigenic epitope. MVA-NP+M1 vaccine use GILGFVFTL epitope and is tested in clinical trial.Potential cross-reactivity with HIV-1 p17 Gag (77-85):Moreover, FluM1 (58-66) share similarities with HIV-1 p17 Gag (77-85) which can potentially show a cross-reactivity between these epitopes. It has been demonstrated a cross-reactivity and results suggest that immunity following infection by Influenza virus causes specific immune response to HIV-1 p17 Gag (77-85).Sequence: Biotin-GILGFVFTL


SB183 1
EUR 210.38
Description: Pan HLA DR-binding epitope (PADRE) is a universal peptide that activates CD4+ T cells which can be used as an agonist adjuvant.

Biotin-MAGE-A1 (278-286)

SB077 1
EUR 112.2
Description: Biotin-MAGE-A1 (278-286) is the N-ter biotinylated version of MAGE-A1 (278-286). Biotin-MAGE-A1 (278-286) can be used in the analysis of antigen-specific T cells. MAGE-A1 protein:MAGE-A1 (278-286) is an epitope of Melanoma Antigen Gene A1 expressed by tumors of different histological types such as on the surface of breast carcinoma cell and is a Cancer/Testis Antigens (CTA). MAGE-A1 is a tumor antigen expressed in 40% of melanoma and contains epitope for binding HLA-A*02:01 molecules and that are recognized by cytotoxic T cells. Applications of MAGE-A1 (278-286): MAGE-A1 (278-286) is used to stimulate specific cytotoxic T cells in PBMCs and to analyze by ELISPOT peptide epitope specificity and cytokine production like IFN-γ. Immunogenicity of MAGE-A1 (278-286) raised the possibility of developing anticancer immunotherapies or vaccinations. MAGE-A1 is also expressed in lung adenocarcinoma and studies suggest that MAGE-A1 may serve to develop Chimeric Antigen Receptor (CAR) T cell therapy using lentiviral vector and show an encouraging tumor-inhibitory efficacy.Sequence: Biotin-KVLEYVIKV

Biotin-MAGE-A2 (157-166)

SB078 1
EUR 112.2
Description: Biotin-MAGE-A2 (157-166) is the N-ter biotinylated version of MAGE-A2 (157-166). Biotin-MAGE-A2 (157-166) can be used in the analysis of antigen-specific T cells. MAGE-A2 protein: MAGE-A2 (157-166) is an epitope of Melanoma Antigen Gene A2 and is one of the most Cancer-Testis Antigens (CTA) overexpressed in tumors of different histological types, such as prostate cancer. Type of MAGE-A expressed in tumors cells varies according to the type of tumor. The expression of MAGE-A2 causes the proliferation of prostate cancer cells and decreases the chemosensitivity. Applications of MAGE-A2 (157-166):MAGE-A2 (157-166) is used to stimulate specific immune response, cytotoxic T cell response and to analyze the cytokine production in PBMCs by ELISPOT assay. In transgenic mouse, it has been demonstrated that MAGE-A2 (157-166) was capable of eliciting a CTL response presented by HLA-A*02:01 molecules. MAGE-A2 (157-166) has been reported to elicit CTL that could lyse tumor cell expressing both HLA-A*02:01 and MAGE-A2 by stimulation of peripheral blood mononuclear cells (PBMCs) with MAGE-A2 (157-166).Sequence: Biotin-YLQLVFGIEV


PTB001 0.1
EUR 409.06
Description: Ca channels

Chicken BIOTIn (B7) ELISA Kit

QY-E81562 96T
EUR 500